СLINICAL EXPERIENCE OF CYTOFLAVIN FOR THE TREATMENT OF DIABETIC FOOT SYNDROME
This article describes the immediate and remote results of studies on the use of parenteral and oral forms of the drug Cytoflavin in patients with diabetic foot syndrome complicated by trophic ulcers of I and II degrees according to the Wagner classification. Priority is given to the assessment of the course of reparative processes, normalization of the balance of prooxidant-antioxidant system in the blood serum of patients, improving clinical and instrumental para-meters of the blood flow.